Market Analysis of Global Pharmaceutical Industries and Trend Estimation Featuring Pfizer, J&J, Abbott, Gilead, Sun Pharma, GSK and Eli Lilly
Research and Markets has announced the addition of the "Market Analysis Of Global Pharmaceutical Industries And Trend Estimation" report to their offering.
The report analyses the global trend of pharmaceutical industries. It gives vivid profile of generic drugs and emerging market across the globe. A comprehensive market analysis of Germany, Russia, US, Australia, China and India has been presented. Analysis covers market capacity, market value, drug consumption, healthcare expenditure, export and import of drugs, retail commercial market, hospital sale, key achievements and developments, markets around different kinds of drugs etc. The report presents financial analysis of top pharmaceutical companies such as Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline, Eli Lilly & Company.
The latest annual reports of all companies were analysed and compared with earlier reports so as to decipher market trends. Key issues involved in pharmaceutical supply chain for optimization have been identified. Management, discussion and analysis reports of global pharmaceutical industries are an added feature of this report. The future global market trend for coming years has been predicted in light of enormous data collected from various sources.
Key Topics Covered:
1. Pharmaceutical And Pharmaceutical Company
1.1 Pharmaceutical Company
1.2 Definition Of Medicinal Product Or Drug
1.3 Classification Of Drugs
1.4 History Of Drugs
1.5 Ancient Pharmacology
1.6 Medieval Pharmacology
1.7 Modern Pharmacology
1.8 Drugs And Intellectual Property Rights
2. Generic Industry
2.1 Generic Industry
2.2 Introduction To The Generic Market
2.3 Leading Companies In The Generic Industry
2.4 The Generic Industry And Mergers & Acquisitions
2.5 Generic Industry & Emerging Markets
2.6 Conclusion To The Generics Industry
3. Pharmaceutical Industries In Selected Countries Of The World
3.1 German Pharmaceutical Industry
3.2 Russian Pharmaceutical Market
3.3 Russian Pharma Company
3.4 Russian Pharmaceuticals Market
3.5 Us Pharmaceuticals Market
3.6 Australia Pharmaceuticals Industry
3.7 China Pharmaceuticals Industry
3.8 Indian Pharmaceuticals Industry
4. Financial Analysis Of Top Pharmaceutical Companies
4.1 Pfizer
4.2 Johnson & Johnson
4.3 Abbott Pharmaceuticals
4.4 Gilead
4.5 Sun Pharma
4.6 Glaxo Smith Kline Annual Report
4.7 Eli Lilly & Company Annual Report
5. Pharmaceutical Supply Chains: Key Issues And Strategies For Optimisation
5.1 Trends In The Pharmaceutical And Related Industries
5.2 Value Chains
5.3 Supply Chains
5.4 Process, Development & Design
5.5 Optimised Planning Of Tests
5.6 Capacity And Portfolio Planning Under Uncertainty
5.7 Combined Testing And Capacity Planning
5.8 Classical Supply Chain Planning And Management
5.9 Issues/Structure
5.10 Dynamic Supply Chain Analysis
5.11 A Particular Market
5.12 Comparison Of Two Supply Chain Responses
5.13 Some Conclusions
5.14 Future Perspectives
6. Management, Discussion And Analysis Report Of Global Pharma Industry
7. Summary
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance